Brain Cancer Treatments

Drug molecules that are too large to cross the blood-brain barrier when administered orally or into veins are being injected directly into brain tissue of patients with primary or recurrent brain cancers in clinical trials. We assist the planning, device placement, and monitoring of the therapy delivery. This work is done with industry and biotechnology partners.